316 related articles for article (PubMed ID: 28472749)
1. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.
Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery.
Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK
Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072
[TBL] [Abstract][Full Text] [Related]
3. Effect of surface properties on liposomal siRNA delivery.
Xia Y; Tian J; Chen X
Biomaterials; 2016 Feb; 79():56-68. PubMed ID: 26695117
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor targeted three-layered micelles and hydrogels for gene delivery to activated macrophages.
Mohammadi M; Li Y; Abebe DG; Xie Y; Kandil R; Kraus T; Gomez-Lopez N; Fujiwara T; Merkel OM
J Control Release; 2016 Dec; 244(Pt B):269-279. PubMed ID: 27565213
[TBL] [Abstract][Full Text] [Related]
6. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
Lee J; Ahn HJ
Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
[TBL] [Abstract][Full Text] [Related]
7. Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes.
Chen Z; Zhang T; Wu B; Zhang X
Int J Nanomedicine; 2016; 11():991-1002. PubMed ID: 27042054
[TBL] [Abstract][Full Text] [Related]
8. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
9. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy.
Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T
Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
[TBL] [Abstract][Full Text] [Related]
11. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes.
Kabilova TO; Shmendel EV; Gladkikh DV; Chernolovskaya EL; Markov OV; Morozova NG; Maslov MA; Zenkova MA
Eur J Pharm Biopharm; 2018 Feb; 123():59-70. PubMed ID: 29162508
[TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arrest growth of chronic myeloid leukemia cells in vitro.
Vysochinskaya V; Zabrodskaya Y; Dovbysh O; Emelyanov A; Klimenko V; Knyazev N; Terterov I; Egorova M; Bogdanov A; Maslov M; Vasin A; Dubina M
Biochimie; 2024 Jun; 221():1-12. PubMed ID: 38215931
[TBL] [Abstract][Full Text] [Related]
14. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
Podesta JE; Kostarelos K
Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563
[TBL] [Abstract][Full Text] [Related]
15. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
16. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
[TBL] [Abstract][Full Text] [Related]
18. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation.
Reddy JA; Low PS
J Control Release; 2000 Feb; 64(1-3):27-37. PubMed ID: 10640643
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and properties of folate receptor-targeted cationic liposomes].
Yan Y; Qi XR
Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
[TBL] [Abstract][Full Text] [Related]
20. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]